by Diana Henry | Jun 16, 2021 | ASPIRE, Industry News, Leadership Tips, What We're Talking About
Digital transformation is defined as a customer-centric reimagination of the future of digital technology into all areas of business, profoundly changing how it operates. But why does this matter? Recently, LTi’s COO, Bill Weeks spoke about digital transformation and...
by Diana Henry | Apr 12, 2021 | ASPIRE, Industry News, Leadership Tips, What We're Talking About
The London Interbank Offered Rate (LIBOR) serves as a globally accepted benchmark interest rate that indicates borrowing costs between banks. It’s a globally recognised base rate for pricing loans, debt, and derivatives. It is estimated that more than $240 trillion in...
by Diana Henry | Mar 4, 2021 | ASPIRE, Industry News, LTi Cloud, Tips and Tricks, What We're Talking About
The financial environment has altered significantly in the UK since the pandemic, putting serious pressure on the asset finance landscape. However, the financial environment has been impacting interactions with customers since before the pandemic as well. Over the...
by Diana Henry | Feb 1, 2021 | ASPIRE, Industry News, LTi Cloud, What We're Talking About
After nearly five decades, Britain has officially left the EU, breathing a new chapter for its future with Europe. This has been a tumultuous road for both parties. The divisive vote to remain in the EU in 2016 revealed more than half of British voters wanting to...
by Diana Henry | Jan 18, 2021 | ASPIRE, LTi Cloud, Marketing Tips, What We're Talking About
Customer loyalty and maintaining relationships with customers have become a focus for equipment finance companies with the coronavirus crisis. Companies want to continue to provide value to their customers and aim to return to growth as soon as they can after the...
by Diana Henry | Jan 4, 2021 | ASPIRE, Industry News, LTi Cloud, What We're Talking About
Last month on Dec. 8, the UK received the first doses of the Pfizer/BioNTech vaccine. On Dec. 11, the U.S. Food and Drug Administration (FDA) approved the Pfizer/BioNTech vaccine for the first emergency use authorisation of the Covid-19 disease. Moderna, now the...
